Comparative study of MP-azeflu in saline nasal irrigation for treatment of allergic rhinitis
Phase 3
Recruiting
- Conditions
- moderate to severe allergic rhinitisMP-azeflu nasal irrigation for control symptom
- Registration Number
- TCTR20210603003
- Lead Sponsor
- HRH Princess Maha Chakri Siridhorn Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
1 moderate to severe allergic rhinitis
2 allergic confirmation test
Exclusion Criteria
1 recurrent epistaxis
2 previous nasal surgery
3 pregnancy
4 immunocompromised host
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method nasal symptom At 4 week and 8 week after start treatment Total nasal symptoms score
- Secondary Outcome Measures
Name Time Method side effect of medication At 4 week and 8 week after start treatment questionnaire